BioMed Research International / 2016 / Article / Fig 1

Clinical Study

The Efficacy and Safety of Fractional CO2 Laser Combined with Topical Type A Botulinum Toxin for Facial Rejuvenation: A Randomized Controlled Split-Face Study

Figure 1

Representative clinical photographs: (a, c) baseline, (b) 12 weeks after the BTX-A + fractionated CO2 laser treatment, and (d) 12 weeks after the saline solution + fractionated CO2 laser treatment.
(a)
(b)
(c)
(d)